Healthcare sector in India is leaping forward with digital innovations at an accelerated pace. Government of India’s initiatives like National Digital Health Mission, integration of artificial intelligence, data governance and 5G services fuelling rapid paradigm shift in the healthcare industry which is already on the threshold of a new era of digital transformation. Covid-19 pandemic primed the evolution of healthcare business models by channelizing novel digital concepts and strategies. Indian Immunologicals Limited (IIL) the Hyderabad based subsidiary of National Dairy Development Board (NDDB) has been in the forefront of business process innovation. Propelling the digital ecosystem, IIL, through its division Human Biologicals Institute, launched its first set of virtual medical representatives, a pioneering alternative to facilitate physician’s interface in form of eMOz i.e. A virtual realm where e-reps can connect with doctors and foster digital relationship.

Speaking on the launch of eMOz, Dr. K. Anand Kumar, Managing Director of IIL said “This generation of healthcare professionals are quite open for digital channels of communication, and we envision to provide an engaging digital experience to our customers while focussing foremost on covering untapped markets”.

On the ground level, unveiling eMOz have witnessed significant interest from doctors. Dr Santosh Kumar Mishra, Senior Obstetric & Gynaecologist from Sanjita Maternity Care & Hospital, Bhubaneswar (Odisha) who interacted through eMOz and placed an order as well, said “There has been a huge emergence of various digital channels in our life post pandemic, experiencing something like eMOz from Indian Immunologicals Limited is unique & interesting. It is more convenient than some of the usual drop-in interactions”

“While in-person rep visits still hold value, eMOz avatars will accentuate digital value perception among all stakeholders”, Vice President, Human Health business, Mr. Shakul Srivastava said.